T
ech
CN
library_books
Mobile
library_books
Laptop/Pc
library_books
Smart Home
library_books
Audio
library_books
Games
Lastnews
Topics
Trending
News
Best Pick
Reviews
How To Do
Search ...
New Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable
Notified -...
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)
Notified -...
Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (ustekinumab)
...
Teva and mAbxience Expand Strategic Partnership to include an additional Oncology Biosimilar Candidate
...
menu
TechCN
person
menu